Expression and potential prognostic value of histone family gene signature in breast cancer

@article{Xie2019ExpressionAP,
  title={Expression and potential prognostic value of histone family gene signature in breast cancer},
  author={Wenting Xie and Jia-Jia Zhang and P-Y Zhong and ShanShan Qin and Han Zhang and Xin Fan and Yu-Zhen Yin and Ruipeng Liang and Yali Han and Yina Liao and Xiaqing Yu and Huideng Long and Zhongwei Lv and Chao Ma and Fei Yu},
  journal={Experimental and Therapeutic Medicine},
  year={2019},
  volume={18},
  pages={4893 - 4903}
}
Breast cancer (BC) is the most common type of malignancy among females worldwide. Histone modifications, which are the major post-translational modifications, have a significant role in cancer development and prognosis. However, whether histone family genes may serve as potential prognostic biomarkers for BC patients has remained elusive. In the present study, RNA-sequencing data were obtained from The Cancer Genome Atlas (TCGA). Differentially expressed genes were identified and Gene Ontology… 

Figures and Tables from this paper

Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients
TLDR
The results suggest that the prognostic model may be a promising biomarker for clinical prediction of RFS in PCa patients.
Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
TLDR
The results demonstrated that these 10 differentially expressed hub genes could be used as potential biomarkers for CRC diagnosis and the prognostic values of these hub genes were confirmed by survival analyses using different CRC patient cohorts.
The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine
TLDR
This study explored transcriptional differences between two invasive breast cancer subtypes using RNA-Seq data deposited in the TCGA-BRCA project and reported that 36 DNA repair genes are overexpressed in a significant number of both IDC and LC patients’ samples.
Identification of a potentially functional circRNA-miRNA-mRNA ceRNA regulatory network in bladder cancer by analysis of microarray data.
TLDR
This study provided significant insights into the molecular mechanisms that regulate the progression of BCa from the circRNA-miRNA-mRNA network view.
Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood
TLDR
The single CpG sites and DMRs that were identified represented significant measurable differences in lung cancer risk, providing new insights into the biological processes of early lung cancer development and potential biomarkers for Lung cancer risk stratification.
Transcriptomic Characterization Reveals Blood-based Molecular Signatures of NSCLC Patients in Response to Anti-PD-1 Therapy Combined with Chemotherapy
TLDR
The molecular and cellular signatures characterized in this study may provide potential blood-based predictors of the response to PD-1 blockade treatment in NSCLC patients.
Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated Carcinogenesis in Gastric Cancer.
TLDR
This study identified several key downregulated proteins involved in cell division and cell proliferation, which included DNA replication licensing factors, replication factor C, origin recognition complex, replication protein A and GINS, and mesenchymal markers, upon CAMKK2 inhibition.
Identifying the Mutational Profile of ABCB5 Upregulation in Colorectal Cancer: A Comprehensive Database Analysis
TLDR
The analysis revealed the genetic effects induced by ABCB5 upregulation are targetable, including evidence of sensitivity to the XPO1 inhibitor XPOVIO (selinexor) and further pre-clinical investigation is needed to validate these findings.
Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood
TLDR
It was found that CpG sites in the HOXA3/HOXA4 region were hypermethylated in cases compared to controls, providing potential biomarkers for lung cancer risk stratification.
Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival
TLDR
A proliferating cell-type (Prol) enriched in HCC tumors is identified, associated with a decreased overall survival, and linked to TP53 and RB1 somatic mutations.
...
1
2
...

References

SHOWING 1-10 OF 40 REFERENCES
Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients
TLDR
Collectively, these results provide evidence that two SLE-associated gene sets can be used as prognostic factors for survival prediction among cervical cancer patients and reveal protective functions of histone genes against DNA damage.
A novel subtype classification and risk of breast cancer by histone modification profiling
TLDR
Compared the genome-wide binding patterns of H3K4me3 and H3k27me3 between human mammary epithelial cells and three breast cancer cell lines representing the luminal, HER2, and basal subtypes, this work provided a valuable resource for the identification of novel biomarkers of subtype classification and clinical prognosis evaluation in breast cancers.
Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity
TLDR
This study suggests that a reduced level of H4K20me3 increases the invasiveness of breast cancer cells in a HER2-independent manner and can be used as an independent marker of poor prognosis in breast cancer patients.
Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors
TLDR
AXL, which encodes a receptor tyrosine kinase, was recurrently overexpressed and amplified in sarcomas, and studies of amplification-dependent overexpression identified potential drug targets in individual tumors.
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.
TLDR
Oncomine, a bioinformatics initiative aimed at collecting, standardizing, analyzing, and delivering cancer transcriptome data to the biomedical research community, provides an update on the initiative, describes the database and analysis modules, and highlight several notable observations.
Histone variant H2A.Z can serve as a new target for breast cancer therapy.
TLDR
Two strategies are proposed here for anti-tumor treatments of H2A.Z function by targeting c-Myc transcription factor and the other is to find potential drug treatment by blocking the activity of H1N1, which leads to tumorigenesis.
The Human Protein Atlas—a tool for pathology
TLDR
An immunohistochemistry‐based map of protein expression profiles in normal tissues, cancer and cell lines is generated and the presented Human Protein Atlas provides a resource for pathology‐based biomedical research, including protein science and biomarker discovery.
Epigenetic mechanisms of breast cancer: an update of the current knowledge.
TLDR
This review of recent knowledge about the role of epigenetic alterations related with DNA methylation and histone modification in breast cancer will summarize the recent knowledge and discuss altered regulation of breast cancer specific genes and the potential of epigenetics therapy.
Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer
TLDR
The findings suggest that H2A.Z.1 plays a pivotal role in the liver tumorigenesis by selectively regulating key molecules in cell cycle and epithelial-mesenchymal transition (EMT) and that it plays established role in accelerating cell cycle transition and EMT during hepatocarcinogenesis.
Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer
TLDR
This study revealed a key pathway that contributes to anthracycline resistance and established model systems for investigating drug resistance in all four major breast cancer subtypes.
...
1
2
3
4
...